• レポートコード:MRC2301C038 • 出版社/出版日:360iResearch / 2022年10月 • レポート形態:英語、PDF、225ページ • 納品方法:Eメール(受注後2-3日) • 産業分類:化学 |
Single User(1名利用、印刷可) | ¥692,860 (USD4,949) | ▷ お問い合わせ |
Enterprise License(企業利用、印刷可) | ¥1,392,860 (USD9,949) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本報告書によると、2021年に306.6億ドルであった世界の組織工学市場規模が、2022年に363.4億ドルになり、2027年まで年平均18.72%で成長して858.6億ドルに達すると予測されています。本資料では、組織工学の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、材料別(バイオミメティック材料、複合材料、ナノ複合材料、ナノファイバー材料)分析、用途別(がん、循環器、歯科、消化器&婦人科、神経科)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの構成でまとめています。なお、本レポートには、BASF SE、Bayer AG、Cook Medical Inc、Corning Incorporated、General Electric Company、Integra LifeSciences Corporation、Johnson & Johnson、Medtronic PLC、Merck KGaA、Novartis AG、Organogenesis Inc、Organovo Holdings, Inc.、Pfizer Inc、ReproCell Inc.、Siemens AG、Smith & Nephew PLCなどの企業情報があります。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の組織工学市場規模:材料別 - バイオミメティック材料の市場規模 - 複合材料の市場規模 - ナノ複合材料の市場規模 - ナノドローンの市場規模 - ナノファイバー材料の市場規模 ・世界の組織工学市場規模:用途別 - がんにおける市場規模 - 循環器における市場規模 - 歯科における市場規模 - 消化器&婦人科における市場規模 - 神経科における市場規模 ・世界の組織工学市場規模:地域別 - 南北アメリカの組織工学市場規模 アメリカの組織工学市場規模 カナダの組織工学市場規模 ブラジルの組織工学市場規模 ... - アジア太平洋の組織工学市場規模 日本の組織工学市場規模 中国の組織工学市場規模 インドの組織工学市場規模 韓国の組織工学市場規模 台湾の組織工学市場規模 ... -ヨーロッパ/中東/アフリカの組織工学市場規模 イギリスの組織工学市場規模 ドイツの組織工学市場規模 フランスの組織工学市場規模 ロシアの組織工学市場規模 ... -その他地域の組織工学市場規模 ・競争状況 ・企業情報 |
The Global Tissue Engineering Market size was estimated at USD 30.66 billion in 2021 and expected to reach USD 36.34 billion in 2022, and is projected to grow at a CAGR 18.72% to reach USD 85.86 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Tissue Engineering to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Material, the market was studied across Biomimetic Material, Composite Material, Nano-Composite Material, and Nano-Fibrous Material.
Based on Application, the market was studied across Cancer, Cardiology, Cord Blood & Cell Banking, Dental, GI & Gynaecology, Neurology, Orthopedics, Musculoskeletal, and Spine, Skin/Integumentary, Urology, and Organ Replacement, Transplants & Ophthalmology.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Tissue Engineering market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Engineering Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Engineering Market, including BASF SE, Bayer AG, Cook Medical Inc, Corning Incorporated, General Electric Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic PLC, Merck KGaA, Novartis AG, Organogenesis Inc, Organovo Holdings, Inc., Pfizer Inc, ReproCell Inc., Siemens AG, Smith & Nephew PLC, Stryker Corporation, Tissue Regenix Group PLC, Vericel Corporation, and Zimmer Biomet Holdings, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Tissue Engineering Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Engineering Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Engineering Market?
4. What is the competitive strategic window for opportunities in the Global Tissue Engineering Market?
5. What are the technology trends and regulatory frameworks in the Global Tissue Engineering Market?
6. What is the market share of the leading vendors in the Global Tissue Engineering Market?
7. What modes and strategic moves are considered suitable for entering the Global Tissue Engineering Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential use of tissue engineering procedures in treating irreversible damage of tissues
5.1.1.2. Need for effective regenerative treatments owing to a rise in the prevalence of diabetes, obesity, and other lifestyle related disorders
5.1.1.3. Increasing prevalence of kidney related disorders
5.1.2. Restraints
5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
5.1.3. Opportunities
5.1.3.1. Technological advancements in the field of 3D tissue engineering
5.1.3.2. Increase in government funding for medical and academic research activities
5.1.3.3. Rapid advances in stem cell research aid in improved disease management
5.1.3.4. Surge in R&D activities to develop tissue engineered products for cardiology
5.1.4. Challenges
5.1.4.1. Stringent government regulations and high cost of treatment
5.2. Cumulative Impact of COVID-19
6. Tissue Engineering Market, by Material
6.1. Introduction
6.2. Biomimetic Material
6.3. Composite Material
6.4. Nano-Composite Material
6.5. Nano-Fibrous Material
7. Tissue Engineering Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Cardiology
7.4. Cord Blood & Cell Banking
7.5. Dental
7.6. GI & Gynaecology
7.7. Neurology
7.8. Orthopedics, Musculoskeletal, and Spine
7.9. Skin/Integumentary
7.10. Urology
7.11. Organ Replacement, Transplants & Ophthalmology
8. Americas Tissue Engineering Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Tissue Engineering Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Tissue Engineering Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. BASF SE
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Bayer AG
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Cook Medical Inc
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Corning Incorporated
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. General Electric Company
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Integra LifeSciences Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Johnson & Johnson
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Medtronic PLC
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Merck KGaA
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Novartis AG
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Organogenesis Inc
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Organovo Holdings, Inc.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Pfizer Inc
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. ReproCell Inc.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Siemens AG
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Smith & Nephew PLC
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Stryker Corporation
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Tissue Regenix Group PLC
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Vericel Corporation
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Zimmer Biomet Holdings, Inc
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
• 英文レポート名:Tissue Engineering Market Research Report by Material, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:組織工学の世界市場予測(~2027)
• レポートコード:MRC2301C038 ▷ お問い合わせ(見積依頼・ご注文・質問)